What question did this study set out to answer?

This study aims to validate integrated pharmaceutical water systems across various subsystems to ensure product quality and safety.

June 1, 2026Open Access

Holistic Validation of Integrated Pharmaceutical Water Systems: From Pretreatment to Pure Steam and Purified Water

Key Points

This study aims to validate integrated pharmaceutical water systems across various subsystems to ensure product quality and safety.
Holistic validation approach employed over multiple production cycles.
Assessment of activated carbon filtration, reverse osmosis, purified water, pure steam, and condensate recovery.
Monitoring of microbial counts, conductivity, and total organic carbon throughout the processes.
Activated carbon filtration and reverse osmosis reduced chlorine to <0.1 mg/L and maintained hardness below 5 mg/L.
Pure steam met WFI-quality with microbial counts ≤3 CFU/100 mL and endotoxin levels <0.05 EU/mL.
Condensate recovery consistently adhered to PW specifications, reinforcing compliance and sustainability.

Abstract

Pharmaceutical water systems are fundamental to product quality and patient safety, requiring rigorous validation across pretreatment, purified water, and pure steam subsystems. This study presents a holistic validation approach encompassing activated carbon filtration (ACF), reverse osmosis (RO), purified water (PW), pure steam, and condensate recovery, with extended determinations across multiple production cycles. Pretreatment with ACF and RO consistently removed chlorine (<0.1 mg/L), maintained hardness below 5 mg/L, and achieved conductivity values of 6–7 µS/cm with microbial counts <100 CFU/mL. These results confirm the protective role of ACF in safeguarding RO membranes and the reliability of RO as the cornerstone of pharmaceutical water purification. Pure steam (PS) met Water for Injection (WFI)-equivalent quality, with conductivity ≤1.0 µS/cm, endotoxin levels <0.05 EU/mL, TOC ≤185 ppb, and microbiological counts ≤3 CFU/100 mL. Purified water remained within pharmacopeial specifications throughout validation, with TOC and microbial monitoring reinforcing reproducibility under routine operating conditions. Condensate recovery consistently met PW specifications (conductivity ≤1.3 µS/cm, TOC ≤150 ppb, microbial counts <2 CFU/mL), demonstrating both compliance and sustainability benefits. Importantly, validation data confirmed stability across production cycles, highlighting condensate recovery as a robust and efficient component of the water purification framework. Overall, the integrated validation confirmed that pharmaceutical water systems not only comply with USP and Ph. Eur. monographs but also demonstrate reproducibility across extended operation. The inclusion of condensate recovery as a validated source of PW represents a novel contribution, enhancing sustainability while maintaining GMP compliance. This holistic validation strengthens the evidence base for reliable and sustainable pharmaceutical water systems.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

1Tania de. La. Cruz, 2Alberto Leyva*, 3Sonny Robles, 4Anabel Duarte, 5José C. Pradere (Mon,) studied this question.

synapsesocial.com/papers/6a1d22f702fbce9130638afc https://doi.org/https://doi.org/10.5281/zenodo.20457501

Bookmark

View Full Paper